Microsoft Corp MSFT:NASDAQ

Last Price$296.37NASDAQ Closing Price as of 4:00PM ET 1/24/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+0.34(0.11%)
Bid (Size)$297.40 (5)
Ask (Size)$297.70 (1)
Day Low / High$276.05 - 297.11
Volume85.7 M

Jazz Pharma Doses First Patient in Late-Stage Combo Trial of Small Cell Lung Cancer Maintenance Treatment

2:52PM ET 11/30/2021 MT Newswires
Jazz Pharmaceuticals (JAZZ) said Tuesday that the first patient has been enrolled in a phase 3 trial evaluating its first-line maintenance treatment for patients with extensive-stage small cell lung cancer.

The trial, which is being conducted in collaboration with F Hoffmann-La Roche, will measure the progression-free survival and overall survival benefits of Zepzelca and Roche's Tecentriq administered in combination and then compared with Tecentriq alone.

Rob Iannone, Jazz 's chief medical officer, said the company has already "witnessed strong clinical demand for Zepzelca as a therapy for metastatic small cell lung cancer patients in the second-line setting."

Price: 119.68, Change: -2.74, Percent Change: -2.23